President, CEO, Director
Mon, Mar 11, 2024
Mar 11
exercised or converted securities in ANIK
20,001 shares @ $0.00
Decreased holdings by -33.30%
Net across this filing: +36.60% (+36,500 shares)
ANIKAnika Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+1.44%
1M+45.69%
3M+46.27%
6M—
1Y—